These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1810470)

  • 1. Clinical significance of the Thomsen-Friedenreich antigen.
    MacLean GD; Longenecker BM
    Semin Cancer Biol; 1991 Dec; 2(6):433-9. PubMed ID: 1810470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers.
    Longenecker BM; Willans DJ; MacLean GD; Selvaraj S; Suresh MR; Noujaim AA
    J Natl Cancer Inst; 1987 Mar; 78(3):489-96. PubMed ID: 3469463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of human tumor associated Thomsen-Friedenreich antigen.
    Samuel J; Noujaim AA; MacLean GD; Suresh MR; Longenecker BM
    Cancer Res; 1990 Aug; 50(15):4801-8. PubMed ID: 2196117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
    Campbell BJ; Finnie IA; Hounsell EF; Rhodes JM
    J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers.
    Zhang S; Zhang HS; Reuter VE; Slovin SF; Scher HI; Livingston PO
    Clin Cancer Res; 1998 Feb; 4(2):295-302. PubMed ID: 9516914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
    Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Krajewski S; Sommer H; Friese K
    Breast Cancer Res Treat; 2007 Jan; 101(1):17-25. PubMed ID: 16807671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the carbohydrate tumour marker SLeX, SLeA (CA19-9), LeY and Thomsen-Friedenreich (TF) antigen on normal squamous epithelial tissue of the penis and vagina.
    Wiest I; Schulze S; Kuhn C; Seliger C; Hausmann R; Betz P; Mayr D; Friese K; Jeschke U
    Anticancer Res; 2007; 27(4A):1981-8. PubMed ID: 17649809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA).
    Fung PY; Longenecker BM
    Cancer Res; 1991 Feb; 51(4):1170-6. PubMed ID: 1825477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune reactivity to Thomsen-Friedenreich antigen in patients with lung cancer detected by superoxide assay-leukocyte adherence inhibition test.
    Ichinose Y; Yagawa K; Kaku M; Hara N; Ohta M
    Cancer Res; 1985 Sep; 45(9):4473-7. PubMed ID: 2992780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection.
    Kumar SR; Sauter ER; Quinn TP; Deutscher SL
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6868-71. PubMed ID: 16203776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma: A clinicopathologic study of 264 patients.
    Baldus SE; Zirbes TK; Hanisch FG; Kunze D; Shafizadeh ST; Nolden S; Mönig SP; Schneider PM; Karsten U; Thiele J; Hölscher AH; Dienes HP
    Cancer; 2000 Apr; 88(7):1536-43. PubMed ID: 10738210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen.
    MacLean GD; Bowen-Yacyshyn MB; Samuel J; Meikle A; Stuart G; Nation J; Poppema S; Jerry M; Koganty R; Wong T
    J Immunother (1991); 1992 May; 11(4):292-305. PubMed ID: 1599915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite effects on human colon cancer cell proliferation of two dietary Thomsen-Friedenreich antigen-binding lectins.
    Yu LG; Milton JD; Fernig DG; Rhodes JM
    J Cell Physiol; 2001 Feb; 186(2):282-7. PubMed ID: 11169464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tandem enzymatic approach for detecting and imaging tumor-associated Thomsen-Friedenreich antigen disaccharide.
    Li Q; Li Z; Duan X; Yi W
    J Am Chem Soc; 2014 Sep; 136(36):12536-9. PubMed ID: 25157422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Thomsen-Friedenreich antigen on human urothelial cell lines detectable by peanut lectin and monoclonal antibody raised against human glycophorin A.
    Radzikowski CZ; Steuden I; Wiedlocha A; Kieler J; Tromholt V
    Anticancer Res; 1989; 9(1):103-7. PubMed ID: 2650614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developments in cancer immunotherapy.
    van den Broek M; von Boehmer L; Knuth A
    Dig Dis; 2010; 28(1):51-6. PubMed ID: 20460890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycan bioengineering in immunogen design for tumor T antigen immunotargeting.
    Sendra VG; Zlocowski N; Ditamo Y; Copioli S; Tarp MP; Bennett EP; Clausen H; Roth GA; Nores GA; Irazoqui FJ
    Mol Immunol; 2009 Oct; 46(16):3445-53. PubMed ID: 19726087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.